Use of tumor treating of recombinant adenoviral P53 products

Use of tumor treating of recombinant adenoviral P53 products

CN
  • CN 100,333,797 C
  • Filed: 01/26/2005
  • Issued: 08/29/2007
  • Est. Priority Date: 01/26/2005
  • Status: Active Grant
First Claim
Patent Images

1. contain the application of compositions in the medicine of the toxic and side effects that the preparation antagonism is caused by antitumor chemotherapy and X-ray therapy of the recombinant adenovirus p53 goods for the treatment of effective dose and pharmaceutically acceptable excipient.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×